๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The methylation of tRNA in KB cells after treatment with actinomycin D

โœ Scribed by Theodore W. Munns; Philip A. Katzman

Book ID
118854579
Publisher
Elsevier Science
Year
1973
Tongue
English
Weight
353 KB
Volume
53
Category
Article
ISSN
0006-291X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Combined actinomycin D and vincristine i
Combined actinomycin D and vincristine in the treatment of patients with cancer
โœ Raul E. Chanes; Paul T. Condit; Richard H. Bottomley; William Nisimblat ๐Ÿ“‚ Article ๐Ÿ“… 1971 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 313 KB ๐Ÿ‘ 2 views

A combination of actinomycin D and vincristine has been used to treat 92 patients with various kinds of cancer. The best results were obtained in patients with lung cancer, with a n initial response rate of 6096 and an average duration of remission of over 8 months. Some patients with sarcomas and m

A phase II evaluation of methyl CCNU and
A phase II evaluation of methyl CCNU and actinomycin D in the treatment of advanced sarcomas in adults
โœ Boh-Seng Yap; Robert S. Benjamin; Michael A. Burgess; William K. Murphy; Joseph ๐Ÿ“‚ Article ๐Ÿ“… 1981 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 280 KB ๐Ÿ‘ 2 views

Twenty-nine patients with metastatic sarcoma were treated with a combination of methyl CCNU and actinomycin D. Patients with adequate bone marrow reserve received methyl CCNU 100 mg/m2 orally on day 1 and actinomycin D 0.3 mg/m2/day intravenously for five days. Both drugs were repeated every four we

Germ cell malignancies of the ovary. Tre
Germ cell malignancies of the ovary. Treatment with vinblastine, actinomycin D, bleomycin and cisplatin containing chemotherapy combinations
โœ James E. Bradof; Dr. Thomas B. Hakes; Manuel Ochoa; Robert Golbey ๐Ÿ“‚ Article ๐Ÿ“… 1982 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 465 KB ๐Ÿ‘ 3 views

Seventeen patients with malignant ovarian germ cell tumors were treated with vinblastine, actinomycin D, bleomycin and cisplatin containing combinations. Many of these patients were heavily pretreated. Thirteen patients had objectively measurable disease and ten (77%) had an objective response (CR o